ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $276,000 | -40.4% | 2,422 | -27.6% | 0.09% | -47.0% |
Q4 2020 | $463,000 | -3.3% | 3,344 | -42.7% | 0.17% | -17.4% |
Q3 2020 | $479,000 | +1128.2% | 5,832 | +556.8% | 0.20% | +168.0% |
Q1 2020 | $39,000 | +178.6% | 888 | +178.4% | 0.08% | +15.4% |
Q4 2018 | $14,000 | – | 319 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |